Panelists discuss treatment decision-making for metastatic non–-small cell lung cancer (NSCLC) with a ROS1 alteration, ...

Patients with lung adenocarcinoma typically carry a mutation in the Epidermal Growth Factor Receptor (EGFR) gene, making them ...

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

A new systemic nutrition-inflammation index predicted perioperative non-small cell lung cancer outcomes better than current ...

A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some ...

The following is a summary of "Clinicopathologic and genomic analyses of SMARCA4-mutated non-small cell lung carcinoma ...

Lung cancer symptoms extend beyond respiratory issues and can manifest as shoulder pain. Tumors pressing on nearby nerves can ...

In this cohort study, geographic access to cancer care was associated with guideline-recommended treatment for early-stage non–small cell lung cancer (NSCLC) and outcomes, particularly in socially ...

Doctors stage non-small cell lung cancer (NSCLC) according to how far it has progressed. Stages range from occult (or hidden) cancer to stage 4 cancer, in which multiple organs may be affected.

Jacobio Pharmaceuticals Group Co., Ltd. ( ($HK:1167) ) has issued an announcement. Jacobio Pharmaceuticals has announced significant progress in ...

Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical ...

A genetic mutation in the lungs can cause non-small cell lung cancer (NSCLC). Different mutations can affect your treatment decisions and outcomes. Genetic testing after a diagnosis of NSCLC is ...